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UNDERSTANDING INTERCELLULAR SIGNALING DURING LUNG INJURY REPAIR

Margo Patricia Cain, B.S.

Advisory Professor: Jichao Chen, Ph.D.

The mammalian lung is a complex system of specialized cell types with precise
spatial organization designed to cooperate to perform gas exchange. These cell types
together coordinate organ development, homeostasis, and repair after injury through signals
either presented or secreted, known as ligands, to be received by receptors on the surface
of another, or in some cases, the same cell. The alveolar region of the lung, the primary
region of gas exchange, responds to various types of injuries with different lung repair
mechanisms. In order to explore how the various cell types in the lung communicate to
drive tissue repair after Sendai virus infection-induced damage, we developed a single-cell
interactome method to uncover novel interactions between epithelial and non-epithelial cell
types. Our interactome method employs a numeric representation of ligand-receptor
interactions and identifies known and potentially new interactions as outliers. Application of
our interactome method to compare control and Sendai virus-infected lung tissue, we
uncovered a signaling relationship between alveolar type 1 (AT1) cells and capillary
endothelial cells. We also applied our interactome to a hyperoxia model for
bronchopulmonary dysplasia, another injury model affecting a majority of lung cell types. In
concert with our sequencing approaches to study cellular interactions, we surveyed Sendai
virus-infected lung tissue to understand the path by which airway basal-like cells migrate
into the regions of alveolar damage, a documented but not well understood phenomenon.
We discovered an association between AT1 cells and these invading airway cells. This
thesis is an exploration of the complex relationships of the cell types that make up the lung
and how they coordinate the mammalian lung’s response to injury and tissue repair.
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Chapter 1: Introduction
1.1 Cells of the lung
Epithelial
The lung is comprised of a system of branching tree-like tube structures forming the
conducting airways ending in a multitude of tiny sacs, alveoli, forming the gas exchange
surface. The airway is made up of a pseudostratifed epithelium composed of Trp63and Krt5-expressing basal cells and luminal cells, the major luminal cells being the
ciliated cells and the secretory or club cells, delineated by the markers Foxj1 and
Scgb1a1 respectively (Treutlein et al., 2014). Ciliated cells are multiciliated cells critical
for mucociliary clearance. Club cells are present in almost the same number in the
mouse conducting airways as ciliated cells and secrete secretoglobins and surfactant
proteins (Whitsett et al., 2019). Also present are the pulmonary neuroendocrine cells
(PNECs), rare innervated cells that contain dense-core vesicles and secretory granules
filled with amines, neuropeptides, and neurotransmitters (Song et al., 2012). PNECs
have been implicated in a variety of lung diseases (Branchfield et al., 2016b).
The alveolar epithelial cells are the alveolar type 1 (AT1) and alveolar type 2
(AT2) cells. The AT1 cells (Rtkn2) are large, ultra-thin cells that form the gas-exchange
surface, while the AT2 cells are the surfactant-producing cells that maintain the surface
tension of the lung, preventing the lungs from collapsing (Whitsett et al., 2019). Each
alveolus consists of a lumen, the airspace, bounded by the AT1 cells, which have an
apical side, the side facing the lumen, and a basal side, the side facing the basement
membrane and the other cell types making up the tissue.
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Endothelial
The pulmonary vasculature is the second branched network present in the lung.
Lymphatic endothelial cells, defined by their Prox1 and Thy1 expression, make up the
lymphatic system, which regulates lung fluid balance (Whitsett et al., 2019). The
arteries and veins, formed by vWF-expressing macrovascular endothelial cells, run
parallel to the conducting airways (Morrisey and Hogan, 2010). The capillaries are
small blood vessels that become tightly associated with the AT1 cells to facilitate gas
exchange (Morrisey and Hogan, 2010). Our lab has identified specific subpopulations
of capillary endothelial cells, the Plvap endothelial cells and the Car4 endothelial cells
(Vila Ellis et al., 2020).
The Plvap endothelial cells comprise the bulk of the endothelial cells and are
more numerous than the Car4 endothelial cells. While fewer Car4 cells, the cell type
discovered in our lab, populate the lung, they are much larger than the Plvap endothelial
cells and are dependent on VEGF signaling from the alveolar epithelium. It was
previously known in the literature that alveolar epithelial cells secreted the angiogenic
ligand VEGFA to stimulate proliferation in KDR-expressing endothelial cells. Our lab
has since identified that specifically the AT1 cells are the source of VEGFA while the
Car4 endothelial cells are the cells responding to the stimulus and participating in
angiogenesis (Vila Ellis et al., 2020; Yang et al., 2016). It is the Car4 endothelial cells
that are physically associated with the folds of the AT1 cells forming the alveoli.

Mesenchymal
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The lung mesenchyme is heterogeneous and poorly understood. Pericytes are
the vessel-associated fibroblasts that wrap around the capillary walls, while vascular
smooth muscle (VSM) cells performs this support and stabilization function for the
macrovasculature, that is, the arteries and veins (Yamazaki and Mukouyama, 2018).
The conducting airways also contain airway smooth muscle (ASM) cells that perform a
similar function for the airway, with contractile properties to control air flow (Amrani and
Panettieri, 2003). The mesothelium lines the lung and is a source of mesenchymal
progenitors for the endothelium, A/VSM, and a population of lung fibroblast (Batra and
Antony, 2015). These are metabolically active cells that respond to noxious stimuli.
Myofibroblasts, mesenchymal cells that express the contractile protein alphasmooth muscle actin (αSMA), encoded by Acta2, are known to play a critical role in
alveologenesis in response to PDGFA signaling, which when disrupted results in
reduced alveolar secondary septation and thus alveolar simplification (Bostrom et al.,
1996; Li et al., 2018; Lindahl et al., 1997). These perinatal myofibroblasts appear
around postnatal day (P)3 and reduce dramatically around P13 (Branchfield et al.,
2016a; McGowan et al., 2008). A subset of myofibroblasts exhibit high expression of
Hedgehog-inhibitory protein (HHIP), which has been demonstrated to be critical for lung
function and maintenance of proper alveolar structure (Lao et al., 2016; Xie et al.,
2018).
In the mature lung, interstitial fibroblasts are the PDGFRA+ fibroblasts. Lung
interstitial fibroblasts produce extracellular matrix (ECM) and are the source of
fibroblasts responsible for fibrosis (Green et al., 2016; Li et al., 2018). Mesenchymal
cells are known to serve support functions by offering signaling niches for stem cells.
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Wnt5a fibroblasts are the mesenchymal cells that secrete Wnts to maintain the AT2 cell
pool by preventing their transdifferentiation into AT1 cells (Nabhan et al., 2018).

Immune
The complexity of the immune system is reflected in the variety of lymphoid and
myeloid lineage cells residing in the lung. The first line of defense upon a pathogen
entering the airway are the sensor cells, club cells, ciliated cells, alveolar macrophages
(AMs), and dendritic cells (DCs), which signal to attract rapid responders such as
neutrophils (Iwasaki et al., 2017). These cells act as messengers and secrete first order
cytokines to alert tissue-resident lymphoid cells including innate lymphoid cells (ILCs),
natural killer (NK) cells, NKT cells, mucosal-associated invariant T (MAIT) cells,
epithelial γδ T cells, and tissue-resident memory T (TRM) cells. Upon stimulation, these
lymphoid cells produce and secrete second order cytokines to recruit the effector cells
to the site of infection (Iwasaki et al., 2017).
The effector cells are generally, CD4+ T (helper) cells, CD8+ (cytotoxic) T cells, and
B cells. These effector lymphoid cells themselves upon stimulation differentiate into a
variety of subsets with very specific functions. Both CD4+ and CD8+ T cells can mature
into memory and effector cells. Upon encountering an antigen-presenting DC in the
lung, CD4+ T cells will differentiate into Th1, Th2, Th17, and/or Treg cells, depending on
the cytokines secreted by the antigen-presenting cell (Chen and Kolls, 2013).
Mononuclear phagocytes consist of monocytes, macrophages, and dendritic cells.
The fractalkine receptor CX3CR1 is expressed by the Macrophage-DC precursor from
the bone marrow that has lost granulocyte potential (Fogg et al., 2006; Jung et al.,
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2000). The lung has two basic flavors of macrophages, one being a resident
macrophage population localized to the airspaces, the well-studied alveolar
macrophages (AMs). These CX3CR1+ alveolar macrophages established
embryonically, have high longevity, and are self-maintained independent from the
circulating monocyte pool (Yona et al., 2013). Interstitial macrophages (IMs) start as
Ly6c+ monocytes from the bone marrow that lose expression of Ly6c before maturation
and differentiation (Geissmann et al., 2010; Yona et al., 2013). The IMs come in three
flavors, MHCII+ CD206+ CD11c-, MHCIIlo CD206+ CD11c-, MHCII+ CD206lo CD11c+
(Gibbings et al., 2017).

1.2 Lung stem cells
Although the adult lung is quiescent at steady state, the lung shows a remarkable
ability to recover and regenerate after insult, injury, and damage, largely due to the
facultative progenitor cell populations that can activate proliferation and differentiation
programs to replenish the various cell types that have been lost. The stem cells appear
to be governed by location (Kotton and Morrisey, 2014).
Basal cells are the stem cells of the trachea and proximal airway. Acute damage to
the proximal airway mobilizes basal cells to proliferate and repopulate the airway with
more basal cells, ciliated cells, and club cells (Hong et al., 2004; Leach and Morrisey,
2018; Rock et al., 2009). The club cells are the facultative stem cells of the distal
airway. Apparently, club cells can also dedifferentiate into basal cells upon basal cell
depletion (Tata et al., 2013; Zheng et al., 2014). The AT2 cells are the facultative stem
cells of the alveolar tissue (Barkauskas et al., 2013; Rock et al., 2011).
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1.3 Sendai virus
Sendai virus (SeV) infection is a model for acute and chronic inflammation and is
used to study non-allergic mechanisms of asthma and COPD pathogenesis. Infection by
paramyxovirus, specifically respiratory syncytial virus, is the leading cause of lower
respiratory tract illness in children and can lead to chronic wheezing (Sigurs et al.,
2000). The SeV bronchiolitis model is characterized by hallmark goblet cell metaplasia,
airway hyperreactivity, and Type 2 inflammation (Holtzman et al., 2005).
SeV, a mouse-specific pathogen, is a non-segmented negative-strand RNA virus of
the family Paramixoviridae and genus Respirovirus identified in Japan in 1953
(Nakanishi and Otsu, 2012). The virus genome is made of 6 cistrons, in gene order: the
nucleocapsid protein (NP), phospho (P) protein, matrix (M) protein, fusion (F) protein,
hemagglutinin-neuraminidase (HN) protein, and large (L) protein (Kato et al., 1996).
The P cistron encodes for the P, C, and V proteins. Because paramyxoviruses have
negative-strand RNA genomes, they require an RNA-dependent RNA polymerase
(RdRp), which must be packaged into the virion. The attachment protein, hemagglutinin
(HA), binds sialic acid, which many cell types express, however, the fusion (F) protein
requires activation for docking and fusion of the virus to the host plasma membrane
(Nakanishi and Otsu, 2012).
Type 2 inflammation is an adaptive immune response associated with increased
airway hyperresponsiveness and eosinophilia in asthma patients. A specialized
subpopulation of CD4+ T cells, T helper type 2 (Th2) cells, secrete the Type 2
inflammatory cytokines IL-4, IL-5, and IL-13 to stimulate downstream responses
mediated by eosinophils, mast cells, basophils, Th2 cells, type 2 innate lymphoid cells
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(ILC2s), also initiating B cell-mediated humoral immunity (Dunican and Fahy, 2015;
Walter et al., 2002). IL-33 was identified as the mediator of the chronic inflammation
phenotype by inducing production of IL-13 and mucus overproduction (Byers et al.,
2013). AT2 cells were discovered to be the source of IL-33 in the mouse, while airway
basal cells were found to be the source in human lungs (Byers et al., 2013).

1.4 Single-cell interactomes
Single-cell RNA-sequencing technology now allows for the capture of this complexity
with even greater resolution that has been possible with bulk sequencing technologies
alone, as a sample’s transcriptome can be examined at the cell level, rather than on the
level of the whole organ or tissue compartment. It is now possible to map out the many
potential interactions possibly occurring in the whole organ between the cell types as a
single snapshot, which can then be followed over time and/or compared to experimental
perturbations of the system (Du et al., 2017; Strunz et al., 2019). However, scRNA-seq
as a tool is still undergoing optimization, both in technology as well as in data analysis
and computational methods. For example, the nature of current scRNA-seq techniques
limits the depth of sequencing, leading to concern over gene dropout in single-cell
versus bulk sequencing methodologies, which have been able to achieve increasing
levels of sequencing depth after decades of use (Hicks et al., 2018; Kharchenko et al.,
2014). For a single-cell interactome, detection of more than the most highly expressed
ligand and receptor genes is desired. Additionally, these considerations must be
balanced with the cost of sequencing adequate amounts of a sample to sufficiently
represent each cell type present in the organ.
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Still, recognizing the power of scRNA-seq, several publications have presented
interactomes constructed from scRNA-seq data. These interactomes have generally
quantified and summarized the number of potential ligand-receptor interactions existing
between each of the cell type-cell type combinations based on transcription (Camp et
al., 2017; Strunz et al., 2019), as well as calculated which interactions occur most
frequently across all cell types (Camp et al., 2017). Each group has a threshold, an
approach adopted in bulk sequencing data analysis, to estimate the biological relevance
of the potential interaction in the sample. Computational methods have been used to
determine the probability an interaction is specific to a particular cell type (Vento-Tormo
et al., 2018; Vieira Braga et al., 2019) and to determine correlation coefficients (Cohen
et al., 2018). These single-cell interactomes have recently been extended to explore
changes in interactions within disease states (Strunz et al., 2019; Vieira Braga et al.,
2019).

1.5 Bronchopulmonary dysplasia
Bronchopulmonary dysplasia (BPD) is the most common complication of premature
birth, diagnosed in approximately one-third of neonates with birth weights less than
1000g. These infants are born with underdeveloped lungs requiring mechanical
ventilation and supplemental oxygen to survive. However, the positive pressure
ventilation and supraphysiological oxygen levels cause injury to the underdeveloped
lungs resulting in respiratory distress syndrome (RDS) (Thebaud et al., 2019). RDS
becomes BPD when the duration of respiratory support lasts beyond 36 weeks
postmenstrual age (PMA) (Berger and Bhandari, 2014).
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Human infants born prematurely are born in the saccular stage of lung development
at 24 through 38 weeks of gestation. The mouse saccular stage of lung development
occurs beginning at embryonic day (E)17.5 until postnatal day (P)5 (Berger and
Bhandari, 2014). The saccular stage of development is an intermediate stage between
branching morphogenesis and alveolarization, where the terminal airways widen and
form saccules, precursors of alveoli. Primary septa are formed where to airspaces
meet. It is during alveolarization that secondary septation occurs (Schittny, 2017).
Exposure of term mouse neonates to high fractions of oxygen has been shown in
the literature to lead to a BPD phenotype, including alveolar and microvascular
simplification (Berger and Bhandari, 2014). In addition, hyperoxia leads to pulmonary
inflammation, which contributes to BPD. There are many experimental protocols to
study BPD in mice that vary the start of supplemental oxygen treatment, the percentage
of oxygen saturation, the duration of treatment, the period of recovery in room air, with
some even including injecting pregnant dams with LPS to mimic prenatal infections,
which has been linked to development of BPD, though this is controversial (Berger and
Bhandari, 2014; Nold et al., 2013; Tibboel et al., 2013; Yee et al., 2009).
Alveolar VEGF is decreased in the lung as a result of hyperoxia treatment, and
inhibited VEGF signaling has been demonstrated to lead to underdeveloped vasculature
and impaired alveologenesis (De Paepe et al., 2010; Le Cras et al., 2002; Maniscalco et
al., 1997). Inflammatory cytokines and oxygen toxicity from reactive oxygen species are
also contributing factors (Gien and Kinsella, 2011).
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Chapter 2: Materials & Methods
2.11 Mouse strains
The following animal strains were used in this dissertation: Rtkn2CreER/+, RosatdT/+
(Madisen et al., 2010), RosaSun1GFP/+ (Mo et al., 2015), and ShhCre/+ (Harfe et al., 2004).
The Rtkn2CreER/+ animal was generated by our lab (unpublished), and the rest of the
animals were obtained from either academic laboratories or commercial sources.
Tamoxifen was administered at P5 (0.4 mg) and P7 (0.5 mg). All animal experiments
were approved by the Institutional Animal Care and Use Committee at Texas A&M
Health Science Center Institute of Biosciences and Technology and MD Anderson
Cancer Center.
2.12 Sendai virus infection
Sendai virus (parainfluenza type 1) strain 52 (ATCC #VR-105,
RRID:SCR_001672) was expanded in primary rhesus monkey kidney cells (Cell Pro
Labs #103-175). Wild-type C57Bl/6 mice obtained from JAX were anaesthetized with
isofluorane, suspended by the maxillary incisors on a dosing board with a 60° incline,
and infected with a sub-lethal dose of 2.1 × 107 plaque forming units (pfu) of virus in 40
µl phosphate buffered saline (PBS) through oropharyngeal aspiration.
2.13 Hyperoxia Animal Model
Newborn P0.5 C57Bl/6 pups from at least 2 litters were pooled and randomly
distributed to either room air (~21% O2) or 95% oxygen for 4 days. Nursing dams were
rotated every 24 hr. Hyperoxia-exposed animals were placed in an A-Chamber
(Biospherix, Lacona, NY) connected to a ProOx 110 controller (Biospherix, Lacona, NY)
that continuously monitored and maintained the oxygen level to 95 ± 2%.
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2.2 Section immunostaining and cell counting
For cell lineage counting by immunostaining, lungs were inflated and harvested
as previously described (Yang et al., 2016). Briefly, mice were anaesthetized using
Avertin (T48402, Sigma) and the lungs perfused with PBS. The trachea was cannulated
and the lungs were inflated to full capacity with 0.5% paraformaldehyde (PFA; P6148,
Sigma) in PBS at 25 cm H2O pressure. The harvested lungs were immersion-fixed in
0.5% PFA at room temperature for 4-6 hr and washed overnight in PBS at 4°C. Section
immunostaining was performed following published protocols with minor modifications
(Alanis et al., 2014; Chang et al., 2013). Fixed lungs were dissected and cryoprotected
overnight at 4°C in 20% sucrose in PBS containing 10% optimal cutting temperature
compound (OCT; 4583, Tissue-Tek). The lobes were then frozen in OCT-filled
embedding molds on a dry ice and 100% ethanol slurry then kept at -80°C until
sectioned. Sections were obtained at 10 um thickness and then blocked in PBS with
0.3% Triton X-100 and 5% normal donkey serum (017-000-121, Jackson
ImmunoResearch). Blocked sections were incubated in a humidified chamber at 4 °C
overnight with the following primary antibodies diluted in PBS containing 0.3% Triton X100: RAGE (rat, 1:1,000, R&D systems, MAB1179), SOX2 (goat, 1:250, Santa Cruz
Biotechnology, SC-17320), Collagen I (rabbit, 1:250, Rockland Immunochemicals, 600401-103-0.1), TrkB (goat, 1:250, R&D systems, AF1494-SP), laminin (rabbit, 1:250,
Sigma-Aldrich, L9393-.2ML), RFP (rabbit, 1:1000, Rockland Immunochemicals, 600401-379), GFP (chicken, 1:5,000, Abcam, AB13970), ERG (rabbit, 1:5,000, Abcam,
AB92513), CD45 (rat, 1:2,000, eBioscience, 14-0451-81), CD3E (Armenian hamster,
1:250, Biolegend, 100301), CXCR3 (rat, 1:250, R&D Systems, MAB1685), E-cadherin-
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AlexaFluor488 (rat, 1:500, eBioscience, 53-3249-80), NKX2-1 (rabbit, 1:1,000, Santa
Cruz, SC-13040), and KI67-eFluor570 (rat, 1:500, eBioscience, 41-5698-82). The
sections were submerged in PBS for 30 min and incubated with 4',6-diamidino-2phenylindole (DAPI) and donkey secondary antibodies (Jackson ImmunoResearch)
diluted in PBS with 0.3% Triton X-100 at room temperature for 1 hr. The sections were
washed again in PBS then mounted with Aqua-Poly/Mount (18606, Polysciences) and
imaged on a Nikon A1plus confocal microscope or an Olympus FV1000 confocal
microscope. For cell lineage counting, 3 images with airway located in the center were
taken from 2 RosaSun1GFP/+; ShhCre/+ lungs, in which all epithelial cells were labeled with
GFP (Little et al., 2019) to allow costaining for endothelial and immune cells. Endothelial
cells (ERG+ nuclei) and alveolar epithelial cells (GFP+ nuclei) excluding the airways
were counted using Fiji’s ‘Find Maxima’ function. Airway epithelial cells were counted by
drawing region-of-interest around airways and by using Fiji to Find Maxima for DAPI.
Immune cells (CD45+ nuclei) and mesenchymal cells (nuclei negative for the other
markers) were counted manually. For KI67+ alveolar epithelial cell counts, 3 images
without airway were taken for 2 BPD experiments, each with 2 mice per group for a total
of 4 mice per group. The number of NKX2-1+ epithelial cells was counted using Fiji’s
‘Find Maxima’ function and NKX2-1+ Ki67+ cells were counted manually.
2.3 Cell dissociation and labeling
Mice were anaesthetized using Avertin injected intraperitoneally, the chest cavity
was exposed, and the lungs were perfused with PBS injected through the right ventricle.
After clearance of circulating cells, the lungs were removed into PBS and finely minced
using forceps. The lung tissue was digested in Leibovitz’s L-15 media (Gibco, 21083-
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027) with 2 mg/mL Collagenase Type I (Worthington, CLS-1, LS004197), 2 mg/mL
Elastase (Worthington, ESL, LS002294), and 0.5 mg/mL DNase I (Worthington, D,
LS002007) for 30 min on a 37°C heat block. The digestion was stopped by addition of
fetal bovine serum (FBS; Invitrogen, 10082-139) to a final concentration of 20%. The
samples were moved to ice and all remaining steps were performed in a cold room. The
tissue was triturated at 15 min into digestion and also after digestion was quenched.
The resulting cell suspension was filtered through a 70

m cell strainer (Falcon,

352350), centrifuged at 5,000 rpm for 1 min, and the pellet resuspended in red blood
cell lysis buffer (15 mM NH4Cl, 12 mM NaHCO3, 0.1 mM EDTA, pH 8.0) for 3 min. The
cells were pelleted again at 5,000 rpm for 1 min and washed with Leibovitz’s L-15 media
with 10% FBS then filtered into a 5 ml tube with a cell strainer cap (Falcon, 352235).
The cells were incubated with the following conjugated antibodies: CD45-PE/Cy7
(BioLegend, 103114), ICAM2-A647 (Life tech, A15452), E-cadherin-A488 (Invitrogen,
53-3249-82) at a concentration of 1:250 for 30 min. The cells were centrifuged at 5,000
rpm for 1 min, washed in Leibovitz’s L-15 media with 10% FBS for 5 min and finally
resuspended with Leibovitz’s L-15 media with 10% FBS and filtered through a strainer
cap. The sample was incubated with SYTOX Blue (Invitrogen, S34857) and sorted on a
BD FACSAria Fusion Cell Sorter. The cells were collected in a volume of 250 ul PBS
with 10% FBS per collection tube.
2.4 FACS sorting and normalization
After exclusion of dead cells and doublets, cells were gated into the 4 cell lineage
populations using a serial gating strategy. All CD45 positive cells were collected as the
immune population; CD45 negative cells exhibiting ICAM2 positive signal were collected
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as endothelial cells; CD45 negative, ICAM2 negative, but E-cadherin positive cells were
collected as epithelial cells; cells negative for all markers were collected as
mesenchymal cells. To determine cell lineage population-specific reduction in viability
after sorting, an equal number of cells from each lineage were mixed and, after adding
fresh SYTOX Blue, resorted to determine the percentages of each lineage. These
percentages were compared to the expected percentage, 25%, and lineage-specific
viability correction factors were calculated and taken into account when combining the 4
lineages for single-cell RNA-seq to achieve as close to equal proportions as possible.
2.5 Single-cell RNA-seq data analysis
2.51 Data generation
The normalized whole lung samples were processed through the Chromium
Single Cell Gene Expression Solution Platform (10x Genomics) using the Chromium
Single Cell 3’ Library and Gel Bead Kit (v2, rev D). The library sequencing was
performed on an Illumina NextSeq500 using a 26X124 sequencing run format with 8 bp
index (Read1). The single-cell reads were aligned against the mm10 mouse reference
genome (provided by 10x Genomics), counted, and aggregated using the Cell Ranger
pipeline (version 3.0, 10x Genomics). Raw data for the P7 wild-type lung and control
and 2 week post-Sendai virus-infected lungs were deposited at GEO under accession
numbers GSE144769 and GSE144678. R code for figures and supplemental tables are
included in Supplemental File 1.
2.52 Cell type identification
Data processing was performed using the R package Seurat (version 3.1.2)
(Butler et al., 2018). Unless specified, default parameters were used. Single-cell count
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data used for all downstream calculations was normalized to the number of reads per
cell using Seurat’s normalization function (normalized UMI). Data was scaled before
undergoing dimensionality reduction using the RunPCA Seurat function. Cells were
visualized on a projection map using the RunUMAP function. Feature plots for known
lung cell type markers were used to identify the cell types clustered using the Louvain
algorithm implemented in the FindClusters function after cells were embedded in a
graph using FindNeighbors. The resolution parameter was adjusted to appropriately
cluster the cells based on the known cellular gene markers. The cell type distributions
were calculated by dividing the number of cells assigned to each cell type by the total
number of cells in the sample. The number of unique genes detected in each cell type
was counted. Dot plots were used to visualize the marker genes identifying each cell
type.
2.53 Detection and quantification of viral transcripts
A custom reference genome was generated by adding the 6 SeV genes to the
existing mouse reference genome (mm10 3.0.0) files (10X Genomics) using CellRanger
version 3.0.2 ‘mkref’ function (10X Genomics). The reads from the single-cell RNA-seq
experiments were mapped to this custom reference genome using CellRanger count.
2.54 Bulk RNA-seq versus scRNA-seq comparison
To calculate the dropout rate of genes in the scRNA-seq data, normalized UMI
averaged across all cells for a given cell type was compared to gene expression
(FPKM) from the corresponding bulk RNA-seq data (AT1 and AT2 cells from
GSE129583; endothelial cells from GSE124324). For genes within specified bins of bulk
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RNA-seq expression values, the fraction of genes with zero expression in scRNA-seq
was calculated and plotted.
2.55 Analysis of the number of genes expressed per cell type
The number of genes expressed by each cell of one cell type was counted. The
cells were ordered both by increasing and by decreasing number of genes expressed.
Then, as one cell was added after another, the number of unique genes detected in that
cell not detected in the previous cells was tallied, resulting in the cumulative number of
unique genes detected for that cell type.
2.56 Interactome analysis
The normalized ligand and receptor gene count data was accessed from the
Seurat object, averaged over all the cells of each cell type, and plotted for each cell type
pair. For each ligand-receptor pair for each cell type pair, we multiplied the average
ligand and receptor gene expression. The heatmap visualizing these values was
created using ggplot2 (version 3.2.1). To identify outlying interactions, we computed the
interquartile range (IQR) across all cell type pairs for each ligand-receptor interaction
and used a cutoff of 3 times IQR.
2.57 GO pathway activation score
The 350 GO Pathway gene lists publicly available (Gene Ontology Consortium;
containing the phrase “SIGNALING_PATHWAY” in the ‘Biological Process’ category)
were used to compute pathway activation scores for each cell type using the
AddModuleScore function in Seurat. Outlier pathways were identified for each cell type
by applying a 1.5 times IQR cutoff across the scores for all cells for each pathway. To
identify possible pathway activation as an outcome of a signaling interaction, the gene
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list for each outlying pathway was used to match the receptor genes of outlying
interactions for the same cell type as the signal receiving cell.
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Chapter 3: Basal-like Sox2+ cells interact with AT1 cells during tissue repair after
Sendai virus infection

3.1 Introduction
Chronic obstructive pulmonary disease (COPD) and asthma are both driven by
inflammation. Sendai virus, a mouse-specific pathogen is used to model both asthma
and COPD due to its induction of both acute and chronic inflammation (Holtzman et al.,
2005). Peak viral titers are measured at 5 days post-infection, and the virus is cleared
by day 12 (Goldblatt et al., 2020; Hines et al., 2014).
Previous studies have taken advantage of the chronic inflammatory aspect of
SeV pathogenesis to identify what signals trigger the switch from acute to chronic
inflammation. Evidence suggests that club cell- and AT2 cell-derived IL-33 is
responsible for production of Il-13, airway hyperreactivity, and mucus overproduction
(Byers et al., 2013; Walter et al., 2002). Byers and colleagues also note the presence
of a Krt5/Trp63-expressing basal-like cell population, normally restricted to the trachea,
colonizing the alveolar regions of epithelial damage as has been observed in mouse
after H1N1 infection (Kumar et al., 2011; Vaughan et al., 2015; Zuo et al., 2015). A
lingering question is how these airway epithelial cells migrate to the sites of epithelial
damage, where the AT2 cells are depleted but the AT1 cells remain.
The docking receptor for SeV, hemagglutinin-neuraminidase (HN), recognizes
sialic acid expressed on many cell types, indicating that SeV has a broad cellular
tropism (Nakanishi and Otsu, 2012). The literature suggests that SeV is infectious to
airways cells, monocytes, macrophages, dendritic cells, endothelial cells, and muscle
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cells (Li et al., 2000; Osterlund et al., 2005; Park et al., 2016; Pirhonen et al., 1999;
Yonemitsu et al., 2000). However, majority of these studies were mainly conducted
using recombinant virus and several of these were carried out in human cell culture.
We decided to use scRNA-seq to identify in what cell types we can detect viral
transcripts. Because SeV has a negative-sense RNA viral genome, any positive sense
RNA will be from viral transcription in the host cell cytoplasm.

3.2 Results
3.21 Viral transcripts are detected in many lung cell types
In order to determine which cells of the alveolar region of the lung are infected by
SeV, we harvested the lungs of control and SeV-infected mice at 1 week and 2 weeks
post-infection and performed scRNA-seq. At 2 weeks after infection, when the virus
had been largely cleared and the lung was undergoing repair (Goldblatt et al., 2020;
Holtzman et al., 2005), scRNA-seq detected infection-induced proliferation of ECs and
alveolar type 2 (AT2) cells, as well as aberrant appearance of the Trp63-expressing
basal-like cells (Fig. 1A, B), reminiscent of pods or lineage-negative epithelial
progenitors observed upon severe H1N1 virus infection (Kumar et al., 2011; Vaughan et
al., 2015; Zuo et al., 2015). We generated a custom reference genome by adding the 6
SeV genes to the existing mouse reference genome (mm10) downloaded from 10X
Genomics. The reads from the single-cell RNA-seq experiments were mapped to this
custom reference genome. Positive strand transcripts specific to viral mRNA were
detected in 12 out of 19 cell types that we identified in the scRNA-seq data (Fig. 1C),
including many non-epithelial cell types, agreeing with previous
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Figure 1: Viral transcripts are detected in both epithelial and non-epithelial cell types.
(A) Uniform Manifold Approximation and Projections (UMAP) plots (left) of scRNA-seq of control
and SeV-infected lungs at 2 weeks post-infection showing 18 cell types, as identified by their
marker genes in a dot plot (right). ScRNA-seq data is from dissociated whole lungs of one
experiment with 1 mouse per group.
(B) Feature plots showing increased proliferation in AT2 cells and endothelial cells (ECs)
(Mki67; arrowhead), as well as basal-like cells (Trp63; arrow) upon infection.
(C) Violin plots showing expression of SeV NP transcript for each cell type in control or SeVinfected lungs 1 week post-infection.
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reports of SeV having a wide cellular host range. Our data do indicate that airway cells
are the primary hosts.

3.22 Sox2+ cells begin basal to AT1 cells then invade into the airspace
In order to understand how these airway-derived Sox2+ basal-like cells migrate in
the tissue, we performed immunostaining on lung tissue at day 12 post-infection, which
is early in the process of Sox2+ cell colonization. The Sox2+ cells are not detectable at
10 days post-infection (unpublished data from Chen lab). In normal lung tissue,
airspaces are bordered by RAGE-expressing, ultrathin AT1 cells. In the tissue between
two layers of AT1 cells reside the other cell types along with extracellular matrix
molecules such a collagen I produced by lung mesenchymal cells (Fig. 2A, B). The
tissue can either be in a wide configuration, fitting multiple cells, or a narrow
configuration, in which only collagen is visible in between the AT1 cells bordering the
airspaces (Fig.2 B). After infection, we observe 3 different phases of migration: basal,
luminal I, luminal II. During the “basal” phase, the Sox2+ cells are basal to the AT1 cells
and are occupying space with collagen I (Fig. 2C). In many instances, the AT1 cell
membrane appears to wrap around a single Sox2+ cells but can also contain a cluster of
Sox2+ cells.
During the luminal phases, we observe Sox2+ cells in the lumen; in some cases a
few cells are potentially in contact with the AT1 cell but in the airspace (luminal I), while
in the more advanced stages of Sox2+ cell colonization, a larger mass of Sox2+ cells are
grouped in the airspace and very few if any are in contact with AT1 cells (luminal II)
(Fig. 2C). Also of note, the AT1 cells that are in close proximity to Sox2+ cells exhibit
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Figure 2: Sox2+ cells begin basal to AT1 cells then invade into the airspace.
(A) Diagram depicting alveoli bounded by RAGE+ AT1 cells (green) with interstitial collagen
(magenta) and lung cells (yellow) comprising the alveolar tissue.
(B) Section immunostaining of control lungs showing airspaces bordered by RAGE-expressing
AT1 cells (green) with collagen 1 staining present in the tissue (magenta) along with DAPI of
interstitial lung cells (yellow). Representative of lungs from two adult animals.
(C) Representative images of section immunostaining performed on SeV-infected lungs 12 days
post-infection. The three stages of Sox2+ (blue) cell migration are shown from where the Sox2+
cells are basal to the AT1 cells (“basal”) identified by RAGE expression (green) and the
presence of collagen I (magenta), which is not present in the airspace, then when a few Sox2+
cells appear in the airspace on the other side of the AT1 cells (“luminal I”) and finally as a mass
of Sox2+ cells not associated with AT1 cells (“luminal II”). Representative of lungs from 4
animals of 2 experiments.
(D) Representative images of section immunostaining performed on SeV-infected lungs from
Rtkn2CreER/+ ; RosatdT/+ mice treated with tamoxifen specifically labeling AT1 cells harvested 12
days post-infection. Rtkn2-labeled AT1 cells (RFP) are interacting with Sox2+ cells during the
basal and luminal I phases. Representative of 6 animals from 2 experiments.
Scale bars, 10um.
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weaker RAGE intensity compared to AT1 cells in unaffected areas of the tissue (Fig.
2C).
Because the genetic markers routinely used to delineate AT1 cells, such as
podoplanin, may also be expressed in the Sox2+ pod cells, we employed a novel
Rtkn2CreER animal model developed in the Chen lab (unpublished) combined with a
tdTomato reporter that when treated with tamoxifen will fluorescently label as many AT1
cells in the tissue as possible. The mice were injected with tamoxifen long before
infection. In the lungs of the tamoxifen-treated Rtkn2CreER/+ ; RosatdT/+ mice we observe
the same three phases, this time with the Sox2+ cells in proximity to AT1 cells labeled
with RFP, confirming that the RAGE stain is not nonspecific or coming from the Sox2 +
cells (Fig. 2D).
We stained the tissue with E-cadherin to determine whether or not the Sox2+
cells are forming adherens junctions with the AT1 cells. Given the appearance of the Ecadherin in a circular morphology around the Sox2+ cells as well as the overlap with
RAGE, the Sox2+ cells appear to be in direct contact with the AT1 cells (Fig. 3A). In
addition, we wanted to determine where the Sox2+ cells are located in relation to the
basement membrane and found that Sox2+ cells can also be localized basal to the AT1
cell basement membrane delineated by laminin immunostaining (Fig. 3B).

3.3 Summary
Two days after peak viral replication, we detected positive strand viral transcripts
from SeV, a negative-stranded RNA virus, in lung cell types besides the expected
airways cells and DCs, including AT1 cells, AT2 cells, Wnt5a fibroblasts, pericytes,
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Figure 3: Sox2+ cells form adherens junctions with AT1 cells and can migrate basal to
AT1 cell basement membrane.
(A) Representative images from tissue sections of SeV-infected lungs harvested 12 days postinfection stained for E-cadherin (red) to demonstrate that Sox2+ cells are forming adherens
junctions between other Sox2+ cells and AT1 cells. Staining performed on 4 animals from 2
experiments.
(B) Representative images from tissue sections of SeV-infected lungs harvested 12 days postinfection stained for laminin (red) to outline basement membrane showing that Sox2+ are
present basal to AT1 cell basement membrane. Staining performed on 4 animals from 2
experiments.
Scale bars, 10um.
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interstitial fibroblasts, B cells, T cells, neu/baso, and potentially NK cells and Plvap
endothelial cells. This finding indicates that SeV infects more cell types in vivo than has
previously been identified in the literature, where such studies have mainly been
conducted in vitro with SeV as a gene delivery tool (Nakanishi and Otsu, 2012). The
fact that relatively fewer cells of each cell type compared to the airway cells are infected
is attributed to the localized areas of damage in the alveolar region of the lung that can
be observed in the tissue (not shown).
There is much that remains not well understood about the phenomenon of the
basal-like Sox2+ cells that have been observed to proliferate and move into the alveolar
regions of damage following infection with influenza or, in this case, SeV (Kumar et al.,
2011; Vaughan et al., 2015; Zuo et al., 2015). Their precise origin, what path they
migrate to reach their final destinations, and what signals attract them are all unknown.
Also, since the AT1 cells remain in the regions of damage and are later replaced by
these migratory Sox2+ cells, how do these two cells types interact? We have observed
this process occurring in three phases, where at the beginning, either or a small cluster
of Sox2+ cells are in contact with the AT1 cells on the basal side of the alveolus beneath
the basement membrane. The Sox2+ cells are also found on the luminal side of the
AT1 cells lining the air space. As the cells advance in the process, the Sox2+ cells
become a mass of cells that once in the lumen are no longer associated with AT1 cells.
The AT1 cells in contact with the Sox2+ cells show dimmer RAGE staining and
ultimately are absent during the luminal II phase, suggesting that the Sox2 + cells are
displacing the resident alveolar epithelial cells. Given the association with the AT1
cells, it is tempting to speculate that the AT1 cells are a source of a signal instructing
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the Sox2+ cells where to go. To uncover such relationships, a method to infer potential
signaling interactions from scRNA-seq data is necessary. With such a method, we can
identify changes in cell communication behavior by examining all lung cell types in
control and infected lungs.
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Chapter 4: Quantitative single-cell interactomes in normal and Sendai virusinfected mouse lungs
[Note: This chapter is based on a manuscript that was deposited in bioRxiv, Cain et al.
2020, with all rights retained by the authors.]
4.1 Introduction
Rather than the specificity of a targeted mutation directed at a single cell type,
viral infection induces a more global pathophysiological response. We are interested in
the epithelial and non-epithelial responses to SeV infection in the lung as a system of
various cell types. In order to investigate the signaling between what cells types
coordinates the lung repair efforts, we need a way to study the global interactions of the
cell types of the lung.
Delineating genome-wide ligand-receptor interactions between all pairwise
combinations of constituent cell types in a given organ, hereinafter named interactomes,
becomes feasible with the advancement of single-cell RNA-seq (scRNA-seq)
technology, where individual cell types can be profiled upon computational, instead of
physical, purification (Han et al., 2018; Tabula Muris et al., 2018). Several such singlecell interactomes have been constructed to characterize organs and cell culture
systems at baseline and upon perturbation (Camp et al., 2017; Cohen et al., 2018;
Kumar et al., 2018; Raredon et al., 2019; Skelly et al., 2018; Vento-Tormo et al., 2018;
Vieira Braga et al., 2019). One method employed in several of these studies is to apply
a threshold to categorize ligands and receptors as present or absent and count these
binary outcomes as a measure of interaction strength between cell types, although the
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numerical expression values available from scRNA-seq can be more effective in
extracting the biological information (Kumar et al., 2018; Vento-Tormo et al., 2018).
Nevertheless, systematic comparison of scRNA-seq and bulk RNA-seq is often
not incorporated into experimental design to allay the known gene dropout concern in
scRNA-seq. In addition, current algorithms and outputs are not readily adopted by
bench scientists without advanced computational skills, a challenge that we overcome
with our interactome approach that we apply to gain a better understanding of the
signaling pathways that are altered upon SeV infection.
4.2 Results
4.21 A systematic comparison of scRNA-seq and bulk RNA-seq
One challenge to construct an interactome using scRNA-seq is the so-called
gene dropout issue where only a few thousand genes are detected in a given cell due to
technical inefficiency, as compared to the 20,000-30,000 genes expected and obtained
by bulk RNA-seq of typical mammalian cells (Hicks et al., 2018; Kharchenko et al.,
2014). However, it is important to recognize that bulk RNA-seq does not detect all
genes in every cell of the sample and the apparent high coverage is the result of
summing over tens of thousands of cells. We thus hypothesized that, by combining cells
of a cell type readily identifiable in scRNA-seq, we could achieve comparable sensitivity
to bulk RNA-seq of the same purified cell type. To test this, we used as a standard our
published bulk RNA-seq data of FACS-purified alveolar type 1 (AT1) and alveolar type 2
(AT2) cells (Little et al., 2019) and evaluated scRNA-seq gene dropouts as a function of
expression level (Fig. 4A). We found that the dropout rate, defined as the percentage of
genes detected by bulk RNA-seq but not scRNA-seq, decreased with increasing
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expression levels, as measured by fragments per kilobase of transcript per million
mapped reads (FPKM) from bulk RNA-seq. For example, only 4% of genes at 10
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Figure 4. Cell type-level scRNA-seq data compares favorably to bulk RNA-seq.
(A) scRNA-seq gene dropout rates of AT1 and AT2 cells, with the number of cells sequenced in
parenthesis, as a function of bulk RNA-seq expression (FPKM) of the corresponding FACSpurified cell types. The dropout rate is the percentage of genes not detected by scRNA-seq for a
given range of bulk RNA-seq expression values. ScRNA-seq data are from postnatal day (P) 7
(GSE144769); bulk RNA-seq data are from P5 for AT1 cells and P8 for AT2 cells, as published
(Little et al., 2019). ScRNA-seq data is from dissociated whole lungs of one experiment with 1
mouse per group. Bulk RNA-seq was performed on 3 mice per group.
(B) Consistency between AT1 cell (left) and AT2 cell (right) gene expression from scRNA-seq
and bulk RNA-seq gene expression of the corresponding cell type. The scRNA-seq equivalent
of the FPKM value in bulk RNA-seq, which sums the expression in all cells of the sample, is
considered the sum of normalized unique molecular identifiers (UMIs normalized by the
sequencing depth of each cell) over all cells in the corresponding cell type. ρ, Spearman's rank
correlation coefficient.
(C) scRNA-seq gene dropout rates of endothelial cell (EC) subpopulations at P7, with the
number of cells sequenced in parenthesis, as a function of bulk RNA-seq expression (FPKM) of
FACS-purified total ECs at P7, as published (Vila Ellis et al., 2019). ScRNA-seq data is from
dissociated whole lungs of one experiment with 1 mouse per group. Bulk RNA-seq was
performed on 3 mice per group.
(D) ScRNA-seq average gene expression for the 4 EC subpopulations, color/symbol-coded as
in (C), as a function of bulk RNA-seq gene expression of total ECs. Over a wide range of FPKM
values, subpopulation-specific genes are readily identifiable in scRNA-seq. Examples are
marked with the same subpopulation symbols but in black. Thy1 is enriched in lymphatic ECs;
Cd24a, Car4, and Igfbp7 are enriched in Car4 ECs; Plvap is depleted in Car4 ECs; Eln is
enriched in Plvap ECs. One outlying, non-differential gene (Malat1; Table S1) is removed to
decompress the plot.
(E) Table showing the first 10 genes for the first 10 cells to illustrate how average and total gene
expression values are calculated. Nonzero values are highlighted in red and tallied to obtain the
number of cumulative unique genes.
(F) The number of genes detected, as tallied in (E), plateaus as a function of the number of cells
sequenced for a given cell type (Plvap ECs of adult lungs). Cells are sorted in ascending (light
blue) or descending (dark blue) order in (E) by the number of genes detected in the cell. The
dashed gray line marks 90 cells.
(G) The number of genes detected for indicated cell types with the number of cells sequenced in
parenthesis. The dashed gray line marks 90 cells. (E-G) use scRNA-seq data from the adult
lung (GSE144678)

32

FPKM were missed in scRNA-seq of 345 AT1 cells and this percentage was
even lower (0.6%) for AT2 cells where 1,252 cells were sequenced. Technical or
biological noise likely dominated for low FPKM genes as 61 and 54 genes were
detected by scRNA-seq but not bulk RNA-seq for AT1 and AT2 cells, respectively. The
consistency between scRNA-seq and bulk RNA-seq was further supported by the good
agreement between the levels of gene expression measured by both methods (Fig. 4B).
After establishing the comparable performance of scRNA-seq and bulk RNA-seq
in measuring the same cell populations, we examined the added benefit of scRNA-seq
in dissecting cell type heterogeneity without prior knowledge and availability of surface
markers or genetic drivers that were necessary for physical purification in bulk RNAseq. For this, we used lung endothelial cells (ECs) that were bulk purified with a pan-EC
marker ICAM2 but contained 4 subpopulations in scRNA-seq: Plvap ECs, Car4 ECs,
Vwf ECs, and lymphatic ECs (Vila Ellis et al., 2019). As before, dropout rates were low
except for lymphatic ECs, probably because only 15 cells were sequenced (Fig. 4C).
However, the apparent higher sensitivity of bulk RNA-seq was likely driven by
expression of those dropout genes in non-lymphatic ECs and not because bulk RNAseq detected mRNAs derived from lymphatic ECs. Nevertheless, cell type heterogeneity
captured by scRNA-seq was demonstrated by comparing population-specific gene
expression as a function of expression in bulk RNA-seq (Fig. 4D). Again as before, the
majority of the genes showed good agreement between scRNA-seq and bulk RNA-seq.
As we hypothesized, cell type-specific genes over a range of expression levels, such as
Cd24a, Car4, and Igfbp7 for Car4 ECs, showed the expected enrichment; the converse
was also true for genes depleted in Car4 ECs, such as Plvap. Notably, Thy1, a known
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lymphatic EC marker (Jurisic et al., 2010), was negligible in bulk RNA-seq but readily
detected and distinguishable in the lymphatic ECs of only 15 cells (Fig. 4D). Such cell
type stratification was, by design, lost in bulk RNA-seq.
The varying performance of scRNA-seq seemingly as a function of cell number
prompted a systematic evaluation: we computationally sampled the Plvap EC
population (Fig. 4E) and found that the number of detected genes rapidly approached
the technical limit such that ~90 cells were necessary to detect 10,000 genes (Fig. 4F).
The same 90-cell cutoff held true when comparing cell types of different cell numbers
(Fig. 4G) and therefore was used to guide the optimization of our scRNA-seq wet-lab
protocol as described below.
Overall, our analyses showed that scRNA-seq performs as well as bulk RNA-seq
in detecting and quantifying genes when computationally combining enough cells for a
given cell type, and outperforms bulk RNA-seq in identifying cell type heterogeneity and
associated marker genes.
2.22 Generation of a quantitative interactome approach
The theoretical minimal number of cells, as determined above, could be difficult
to obtain in practice, due to highly skewed proportions of the dozens of cell types in a
typical mammalian organ. For example, published lung scRNA-seq datasets had limited
representation of endothelial and mesenchymal cells and significant variations in cell
proportions across experiments (Fig. 5A). We reasoned that consistent and sufficient
sampling of major lung cell types could be achieved by first purifying and then
sequencing equal proportion of the 4 cell lineages – epithelial, endothelial, immune, and
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Figure 5: Optimized sample preparation protocol for scRNA-seq captures major lung cell
types of the epithelial, endothelial, immune, and mesenchymal lineages.
(A) Distribution of the 4 color-coded lineages quantified from published whole lung scRNA-seq
datasets (Angelidis et al., 2019; Reyfman et al., 2019; Strunz et al., 2019).
(B) Confocal images of immunostained adult RosaSun1GFP/+; ShhCre/+ lungs where epithelial cell
nuclei are genetically marked by nuclear envelope-targeted GFP (Mo et al., 2015), whereas
ERG and CD45 mark endothelial and immune cells, respectively, and triple negative nuclei
(DAPI) are considered mesenchymal. We used the GFP reporter instead of NKX2-1 because
both NKX2-1 and ERG are rabbit antibodies. Percentages are from 2 lungs with 3 images each
containing thousands of cells. Scale: 10 um.
(C) An all-inclusive FACS gating strategy to separate all live cells (Sytox Blue negative) into the
4 lung cell lineages.
(D) Skewed distributions of the 4 color-coded lung cell lineages from FACS are compensated by
remixing them in equal proportions, adjusted for lineage-specific cell viability, for scRNA-seq.
3,245 cells were sequenced. Distributions of the constituent cell types in each lineage can be
obtained from scRNA-seq. airway cells: ciliated and club cells; NK cells: natural killer cells; AM:
alveolar macrophages; mono: monocytes; IM: interstitial macrophages; DC: dendritic cells; neu:
neutrophils; baso: basophils; A/VSM: airway/vascular smooth muscle cells. ScRNA-seq data is
from dissociated whole lungs of one experiment with 1 mouse per group
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mesenchymal lineages, which were generally considered non-interconvertible. As a
benchmark, we determined via immunostaining the in vivo average proportions of the 4
listed cell lineages as 26%, 38%, 17%, and 19% – a skewed and variable distribution
that warranted consideration in experimental design (Fig. 5B). We then identified 3 cell
surface markers that robustly distinguished the 4 lineages in FACS and, in comparison
with our immunostaining results, introduced biases presumably due to varying efficiency
in dissociating cells of different lineages (Fig. 5C). To reduce the cost of scRNA-seq, we
remixed and sequenced equal numbers of cells from the purified 4 lineages after taking
into account lineage-specific difference in cell viability (Fig. 5C).
This cell-lineage-level normalization was a cost-effective trade-off between nonselective whole lung scRNA-seq and in-depth albeit narrow-focused cell type-specific
scRNA-seq. Proportions of cell lineages and individual cell types within a lineage could
be retrieved by analyzing FACS and scRNA-seq data, respectively (Fig. 5D). Our
method routinely captured 18 lung cell types in a sufficient number to construct the
interactome.
As ligand-receptor interaction was directional – consisting of ligand-expressing
signaling cells and receptor-expressing receiving cells, we evaluated each cell type in
our scRNA-seq for its potential as ligand-expressing cells when paired with each of all
cell types, including itself in the case of autocrine interaction (Fig. 6A). For each of these
directional cell type pairs, we used a scatterplot to visualize all 2,356 ligand-receptor
pairs such that a data point off both axes indicated the presence of the corresponding
ligand and receptor, as exemplified by the expected Vegfa-Kdr expression in the AT1
cell-Car4 EC pair (Vila Ellis et al., 2019; Yang et al., 2016) (Fig.
37
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Figure 6: Constructing interactomes using numerical representations of ligand-receptor
interaction capitalizes on quantitative information from scRNA-seq.
(A) Schematic illustrating ligand-receptor interactions between directional cell type-pairs.
Autocrine (between the same cell type albeit not necessarily the same cell) interactions are
boxed in red along the diagonal. A hypothetical cell type-pair (D to B) illustrates the locations of
possible ligand-receptor interactions, as demonstrated in a real example showing a known
Vegfa-Kdr interaction from AT1 cells to Car4 ECs.
(B) Table illustrating that for a given ligand-receptor pair, the interaction strength for each
directional cell type-pair is defined as the product of the average ligand expression in the
signaling cells and the average receptor expression in the receiving cells.
(C) Heatmaps to visualize the hypothetical table in (B) for 2 real ligand-receptor interactions
known to occur between AT1 cells and Car4 ECs via Vegfa-Kdr and between ECs and pericytes
via Pdgfb-Pdgfrb. The cell types for the columns are not fully labeled but are in the same order
as those for the rows, as in (B).
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6A). In these scatterplots, user-defined horizontal and vertical thresholds could be used
to tally all ligand-receptor pairs present in specific cell type pairs – an approach
commonly employed in the literature but at the expense of available quantitative
expression values (Camp et al., 2017; Cohen et al., 2018; Skelly et al., 2018).
Furthermore, the number of ligand-receptor pairs was not necessarily a valid predictor
of functional interactions, and a single threshold was unlikely to suit all ligands and
receptors expressed at varied levels.
To overcome these limitations, we sought a numeric representation of ligandreceptor interaction, which we reasoned should positively correlate with the expression
values of both the ligand and the receptor. Inspired by the principle of chemical
equilibrium where the product –the ligand-receptor complex in this case, which should
determine the signaling output – equals the product of the substrates divided by the
equilibrium constant, we chose to represent the interaction strength by multiplying the
average scRNA-seq expression values of the ligand and the receptor in the involved cell
types (Fig. 6B). By assuming comparable protein translation and delivery among cell
types, this numeric representation allowed us to leverage 324 cell type pairs for a given
ligand-receptor pair and readily captured potential interactions as outliers. This was
demonstrated using heatmaps for the known interactions between AT1 cells and Car4
ECs via Vegfa and Kdr, and between ECs and pericytes via Pdgfb and Pdgfrb (Fig. 6C).
These visually outlying interactions were quantitatively defined as those outside 3 times
the interquartile range.
4.23 Application of the single-cell interactome algorithm to the Sendai virus
infection model
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Next, we extended our numeric interactome analysis to compare lungs at
baseline and upon perturbation. For each directional cell type pair, we compared control
and infected lungs by plotting the corresponding numeric interactions of individual
ligand-receptor pairs, such that data points above or below the diagonal line
represented enhanced or diminished interactions, respectively, whereas those on the y
or x axis represented de novo or lost interactions, respectively. One example was an
infection-induced interaction between myeloid cells and T cells via Cxcl9 and Cxcr3
(Fig. 7C, D). This was supported by CXCR3 immunostaining, showing its upregulation
in clustered T cells possibly as a result of chemotaxis (Groom and Luster, 2011; Weng
et al., 1998) (Fig. 7E).
To quantify infection-induced changes in interactions, we resorted to the
aforementioned concept of outliers by pooling the differences in a given ligand-receptor
interaction across 324 cell type pairs and used the same 3 times interquartile range
cutoffs. We found that 3.6% (27,611 out of 763,344) interactions were outliers, involving
448 and 433 unique ligands and receptors in 289 cell type pairs and averaging 85
outlying interactions per cell type pair.
To corroborate our interactomes and capitalize on the transcriptomic information
available from scRNA-seq, we sought to analyze the activities of signaling pathways
and integrate them with associated ligand-receptor pairs. We chose signaling pathways
annotated by Gene Ontology, instead of Ingenuity Pathway Analysis, because of its
public availability and inclusiveness. Although these databases did not take into account
specific biological contexts, limiting their use in general, we reasoned that by averaging
over a sufficient number of bona fide, context-independent pathway members, a
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Figure 7: Interactome analysis identifies outlying changes in interaction upon Sendai
virus infection.
(A) Schematic illustrating comparison of control and Sendai virus-infected lungs for each
directional cell type-pair. Autocrine interactions are boxed in red along the diagonal. A
hypothetical cell type-pair (D to B) illustrates the locations of possible changes in interactions,
as demonstrated in a real example showing 2 color-coded interactions. Cell types are
abbreviated as in Fig. 2D.
(B) Dot plots showing upregulation of Cxcl9 and Cxcr3 upon infection.
(C) Confocal images of immunostained control and Sendai virus-infected lungs showing
upregulation of CXCR3 in T cells (CD3E), especially when clustered possibly as a result of
chemotaxis via CXCR3 (arrows). Asterisk: non-specific extracellular matrix staining. Scale: 10
um. Representative images were choses from 3 experiments each with n=3 for each group.
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pathway signature might be still detectible, as assumed in gene set enrichment analysis
(Subramanian et al., 2005).
We considered all genes in a pathway as a metagene and generated the
corresponding metagene (i.e. pathway) score for each cell, which was then averaged
over each cell type (Fig. 8A). Using the same outlier concept, albeit with a less stringent
cutoff of 1.5 times the interquartile range due to the limited number of cell types
available, we pooled individual pathway scores, as well as their changes upon infection,
across 18 cell types, and identified outlying pathways. We identified 4% (276 out of
6,300) outlying pathways at baseline and 5% (321 out of 6,300) outlying alterations
upon infection. To integrate with our interactomes, for a given outlying ligand-receptor
pair, we required the receptor to be a member of an outlying signaling pathway in the
same cell type as the receiving one in the interactome (Fig. 8A). This integration led to
0.3% (2,323 out of 763,344) outlying interactions at baseline and 0.7% (5,516 out of
763,344) outlying alterations upon infection that were also supported by the
corresponding pathway activation. One example was infection-enhanced Bdnf-Ntrk2
signaling from AT1 cells to ECs, largely driven by Ntrk2 upregulation (Fig. 8B). It was
tempting to speculate that the supposedly angiogenic role of this signaling (Dalton et al.,
2015; Kermani and Hempstead, 2007) contributed to the infection-induced EC
proliferation (Fig. 8B).
4.24 TrkB expression is enhanced in endothelial cells of Sendai virus-infected
lungs
The TrkB (Ntrk2) receptor is an effector of the BDNF signaling pathway. It has
been implicated in angiogenesis but little of its role in angiogenesis has been studied
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Figure 8: Integration of interactome and pathway scores to prioritize interactions.
(A) Schematic illustrating the integration of outlying interactions (left) and outlying pathways
(right) occurring within the same receiving cell type. Common outliers in interactions/pathways
or their changes have the receptor gene included in the pathway gene list in the same receiving
cell type.
(B) Dot plots and heatmaps illustrating a real example of Bdnf-Ntrk2 being both an outlying
interaction and an outlying pathway in ECs (double arrowhead). The BDNF pathway is also
outlying for the Wnt5a fibroblast population upon infection (asterisk) – likely driven by increased
Bdnf expression (dot plot), which is not identified as an outlying ligand-receptor interaction as
expected from our algorithm, demonstrating the utility of the integrated analysis.
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Figure 9: Lung endothelial cells exhibit enhanced TrkB expression after SeV infection.
(A) Representative images of section immunostaining performed on SeV-infected lungs
harvested 2 weeks post-infection. SeV-infected endothelial cells (ERG+ nuclei, green) show
TrkB (red) staining compared to control endothelial cells. Staining was performed on lung tissue
of 1 control and 1 infected mouse each from 3 separate experiments.
Scale bars, 10um.
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(Kermani and Hempstead, 2007). We found TrkB-expressing endothelial cells in both
control and SeV-infected tissue, as seen by overlap of TrkB with ICAM2. As was
observed in the dotplot, TrkB+ endothelial cells exist in control lungs, though they are
relatively rare. However, in SeV-infected tissue, a majority of the vasculature is TrkB
positive with more intense expression visible than in control lungs (Fig. 9A).

4.3 Summary
Meaningful interpretation of rapidly-growing single-cell data depends on
biological insights of bench scientists, who are often discouraged by the complexity of
existing computational tools. As bench scientists ourselves, we describe here optimized
experimental and computational methods to construct single-cell interactomes in lungs
at baseline and upon infection. Our approaches are intuitive and readily adaptable to
study other organs and species by those equipped with a consumer-grade computer
and an intermediate level of R programming skills, but without formal education in
computer and statistical sciences. Our interactome improves upon existing ones (Camp
et al., 2017; Cohen et al., 2018; Kumar et al., 2018; Raredon et al., 2019; Skelly et al.,
2018; Vento-Tormo et al., 2018; Vieira Braga et al., 2019), in the following 3 aspects.
First, we systematically evaluate and then capitalize on our observations that, on
the cell type level, scRNA-seq has comparable sensitivity to genetic driver-based bulk
RNA-seq and yet is more robust in identifying and purifying a given cell type (Fig. 1).
Our cell type-level analysis bypasses the gene dropout issue inherent to scRNA-seq
and imputation methods that are still under development (Gong et al., 2018; Hicks et al.,
2018; Huang et al., 2018; Kharchenko et al., 2014; van Dijk et al., 2018).
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Experimentally, our normalization method is guided by computational assessment of the
minimal cell number needed and captures all major lung cell types without inhibitory
cost or resorting to non-commercial platforms. A potential concern about cell type-level
analysis is failure to capture cellular heterogeneity; this, however, can be alleviated by
careful cell type identification. Furthermore, a cell type that is not sufficiently distinct or
abundant may not be reliably analyzed even with individual-cell-level algorithms, as
evidenced by the significant cell-cell variation of lymphatic ECs (Fig. 1C). While not
applicable to the paired control and infected lungs in our study, batch effects should be
considered in experimental design and could be computationally ameliorated (Butler et
al., 2018; Haghverdi et al., 2018; Polanski et al., 2020) – a preprocessing step
compatible with our interactome algorithm.
Second, we assign significance based on the concept of outliers, made possible
by our numeric representation of ligand-receptor interactions and our normalization
protocol to profile a large number of cell types. Alternatively, significance was computed
by permutation to evaluate observed versus expected expression in individual cells
(Vento-Tormo et al., 2018; Vieira Braga et al., 2019). While the permutation method is a
formal test of statistical significance that is applicable to even a small number of profiled
cell types and can account for multiple hypothesis testing, our interquartile range
method focuses on biological significance and, by using other cell types as internal
controls to identify outliers, mimics in vivo competition among cell types to achieve
specific signaling. Ligand and receptor expression values could also be thresholded to a
binary outcome, which was counted or cross-correlated to represent the interaction
strength between cells (Camp et al., 2017; Cohen et al., 2018; Skelly et al., 2018).
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However, counting interactions may miss functional interactions that are few in number;
thresholding at an early step may introduce irremediable bias. Our analysis preserves
numeric representations of interactions and pathway scores so that users can define
and adjust cutoffs afterwards – 1.5 or 3 times the interquartile range in this case.
Independent from our work, numeric interaction scores can also be used to correlate
with other biological scores (Kumar et al., 2018).
Last, we supplement our interactomes with signaling pathway scores to allay the
concern of inferring functionality solely based on ligand-receptor expression. Prior
knowledge, including the ligand-receptor pair list and pathway components collected by
Gene Ontology or Ingenuity Pathway Analysis, is necessary for bioinformatics but
largely ignores specific biological contexts; the resulting analysis often errs on the side
of false positives. Integrating interactomes with pathway scores, both of which are
based on correlations and likely include false positives, allows for prioritizing candidate
genes for experimental validation. The accuracy may be further improved by better
knowledge of ligand-receptor biology, including elucidation of signal transduction
components and transcriptional targets of individual ligand-receptor pairs. New
computational methods such as NicheNet, like our approach, evaluate downstream
signaling to better predict functional interactions. NicheNet computes and visualizes
ligand-target links using their “prior model” of integrated data sources linking ligands to

downstream transcriptional regulators to target genes, which allows them to rank
ligands in the signaling cells as well as downstream targets in the receiving cells
(Browaeys et al., 2020).
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Chapter 5: Application of the interactome method to the hyperoxia model of
bronchopulmonary dysplasia

5.1 Introduction
Bronchopulmonary dysplasia (BPD) is the most common complication of
premature birth with extremely low birthweight being the highest risk factor for
development of this disease (Thebaud et al., 2019). Pre-term infants are born with
underdeveloped lungs and often need respiratory support including positive-pressure
ventilation and supplemental oxygen to survive (Berger and Bhandari, 2014). However,
these supports significantly contribute to development of BPD. Treatment of neonatal
mice with hyperoxia leads to a BPD phenotype, including alveolar and microvascular
simplification (Thebaud et al., 2019).
Mice are useful for modeling this disease because mice born at term are born in the
same stage of lung development as the stage occurring when human infants are born
prematurely. One caveat to consider, however, is that mouse lungs are able to perform
gas exchange and allow for survival outside of the uterus, which human lungs are
unable to do at this stage (Berger and Bhandari, 2014). Because for this model all of
the cells of the lung are exposed to hyperoxia, the cells are likely communicating with
each other to coordinate a response to oxygen toxicity and damage.

5.2 Results
5.21 TRAIL-activated apoptosis signaling is activated in lung endothelial cells
exposed to acute hyperoxia
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In order to gain a more molecular understanding of how hyperoxia treatment
leads to alveolar simplification, we performed immunostaining on lung tissue harvested
from P0.5 pups exposed to (95% O2) or room air (~21% O2) for 4 days. We observed
less proliferation in AT2 cells at p4 after hyperoxia treatment (Fig. 10A).
Given the fact that all of the cells of the lung are exposed to hyperoxia leading to
underdeveloped alveoli and vasculature, we wanted to know what signals are being
sent as the cells respond to the oxygen. Therefore, we applied our interactome
approach to lungs harvested from animals treated with either hyperoxia or room air for 4
days following birth (Fig. 10B).
Of note, the epithelial cell types, AT1, AT2, and airway cells, had only 1 or 2
outlying GO pathways and none of these intersected with outlying ligand-receptor pairs.
Additionally, we found that TRAIL-activated apoptotic signaling pathway was an outlying
GO pathway in Plvap endothelial cells, mainly driven by expression of the receptor
TNFRSF10B with the ligand TNFSF10 having enhanced expression in all of the
endothelial cell types (Fig. 10C, D). The GO pathway is considered outlying for both
Plvap endothelial cells and mature vessels but not for Car4 cells (Fig. 10D).

5.3 Summary
I found that 4 days of treatment with hyperoxia after birth may reduce
proliferation of alveolar epithelial cells in the developing lung. After application of the
interactome method, I found that TRAIL-activated apoptotic signaling may be stimulated
in lung endothelial by lung epithelial cells driven by de novo expression of the receptor
TNFRSF10B. This result is unsurprising given that oxygen toxicity leads to apoptosis.
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Figure 10: The Tnfsf10-Tnfrsf10b interaction is outlying for endothelial cells exposed to
hyperoxia.
(A) Plot of cell counts showing the percentage of alveolar epithelial cells that are KI67+ after
exposure to hyperoxia (95% O2) or room air (21% O2). Results are shown of 2 separate
experiments with 2 mice per group. Cell counts are a result of 3 images per animal.
(B) Uniform Manifold Approximation and Projections (UMAP) plots (left) of scRNA-seq of
normoxic and hyperoxic lungs treated for 4 days following birth with either 95% oxygen.
Nineteen cell types were identified by their marker genes in a dot plot (right). ScRNA-seq data
is from one experiment performed on dissociated whole lungs of 2 mice per group mixed before
sorting.
(D) Heatmaps illustrating a real example of Tnfsf10-Tnfrsf10b being both an outlying interaction
and an outlying pathway in ECs (double arrowhead).
(C) Dot plots showing gene expression of Tnfsf10 and Tnfrsf10b in each cell type comparing
normoxic (control) and hyperoxic lungs (BPD).
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Chapter 6: Summary and Future Directions
The complex and dynamic signaling interactions carried out between the various cell
types of the lung to coordinate injury repair are not well known. While past efforts have
mainly focused on the inflammation component of respiratory virus pathophysiology, we
have an interest in gaining a better understanding of the lineage-negative epithelial
progenitors, or basal-like Sox2+ cells, that have been described to populate the
damaged lung parenchyma after viral infection by influenza and by the pathogen used
in this study, SeV. We describe a model for how the AT1 cells serves as a physical
template for Sox2+ cell colonization of the regions of SeV damage. According to
Kanegai and colleagues, these cells rarely transdifferentiate into AT1 cells, largely due
to Notch signaling (Kanegai et al., 2016; Vaughan et al., 2015). The observation that
the AT1 cells associated with the Sox2+ cells consistently exhibit weaker RAGE staining
combined with the fact that later on, in the luminal II phase these AT1 cells are no
longer around leads us to believe that the AT1 cells may be dying. In order to explore
this possibility, we would like to perform immunostaining looking for apoptotic markers,
such as cleaved caspase 3 in the AT1 cells with weaker RAGE signal. Our laminin and
E-cadherin immunostaining suggests that Sox2 cells can both be located basal to the
AT1 basement membrane and also can form adherens junctions with AT1 cells, though
it is not possible for these to occur simultaneously. It could be possible that Sox2+ cells
break down the AT1 cells basement membrane and form epithelial contacts before
invading through to the air apace. We would like to test this theory by evaluating
laminin and E-cadherin staining together.
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We performed single-cell RNA-seq and found that SeV infects cell types from all 4
cell lineages. A future study would be to confirm this by immunostaining using the SeVspecific antibody while co-staining for known markers of the different cell types. In order
to explore how the whole organ communicates with itself to drive a repair response to
the viral infection-induced damage, we developed a single-cell interactome method to
uncover novel interactions between epithelial as well as non-epithelial cell types. A
comparison of the gene dropout rate of scRNA-seq against bulk RNA-seq, which
sequences at greater depth, for the same cell type revealed that scRNA-seq performs
comparably when enough individual cells (~90) are sequenced for that cell type. We
also demonstrated the ability of scRNA-seq to capture cellular heterogeneity that bulk
RNA-seq was not designed to achieve. In order to sequence enough cells of each cell
type to satisfy our cutoff and overcome the dropout rate concern, we designed a wet lab
protocol for the normalization of the four lung cell lineage populations after FACS
isolation that can be adapted to the needs of the experiment.
The interactome method we created employs a numerical representation of each
ligand receptor interaction between each cell type pair combination based on the
quantified average gene expression of each ligand and receptor. In order to identify
outlying interactions, we implemented a 3 time the interquartile range (IQR) threshold.
Using this method, known interactions from the literature were found to be outlying in
the expected cell types in our control lung sample. To apply the interactome to our
SeV-infected versus control lung scRNA-seq dataset, we calculated the differences of
the interaction metric and found Cxcl9-Cxcr3 as an outlying interaction between myeloid
cells and T cells, supported by expression of CXCR3 in T cells of SeV-infected lung
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tissue by immunostaining. As a final step in our interactome approach, we devised a
method for prioritizing potentially functional interactions by comparing outlying
interactions, or differences in interactions, to outlying activated signaling pathways in
the receptor-presenting cell type using the GO pathways gene list. We identified a role
for AT1 cells signaling to capillary endothelial cells through Bdnf-Ntk2.
The finding that BDNF and TrkB signaling, which has been implicated in
angiogenesis in a very limited number of studies, may be occurring between AT1 cells
and Plvap endothelial cells is promising. According to our scRNA-seq data and to
preliminary tissue staining, TrkB+ endothelial cells are present in the lung at steady
state, though they are rare compared to the entire lung vasculature. However, 2 weeks
post-SeV infection, dramatically more of the vasculature appears to be TrkB positive, in
agreement with the sequencing data. We would like to quantify and compare how much
of the vasculature expresses TrkB in control versus SeV-infected tissue and to identify
the timing of this signaling interaction. In order to determine the role of BDNF signaling
through TrkB during SeV-induced injury repair, we would like to treat mice with ANA-12,
a TrkB chemical inhibitor (Cazorla et al., 2011; Dalton et al., 2015), 7 days post-infection
until sacrifice of the animals at day 14 to see if there are any vascular phenotypes. We
would also like to generate a conditional deletion animal model of Ntrk2CKO/CKO;
Cdh5CreER/+ and infect these mice, treating control and infected mice with tamoxifen at
the same optimized time point (Luikart et al., 2003; Wang et al., 2010).
Finally, I found evidence that alveolar epithelial cell proliferation is reduced in the
lungs of P4 mice exposed to 95% oxygen (hyperoxia) for 4 days following birth. We
would like to determine whether specifically the AT2 cell population is less proliferative.
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Through application of our interactome method to scRNA-seq performed on dissociated
lungs of mice sacrificed after 4 days of hyperoxia treatment following birth, we identified
Tnfsf10-Tnfrsf10b signaling, belonging to TRAIL-activated apoptotic signaling, occurring
between the endothelial cell populations. We would like to validate this interaction by
staining for the TNFRSF10B receptor and also by quantifying endothelial cell apoptosis
in the tissue.
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